Published in Proteomics Weekly, January 4th, 2010
"KA showed a moderate anti proliferative effect in MTT assay towards all cancer cells (IC50, 9.1-14.3 mu g ml(-1)). However, KA appeared not selective to cancer cells, since it also inhibited the lymphocytes proliferation (IC50, 12.6...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly
Source: Proteomics Weekly (2010-01-04)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.